表紙
市場調查報告書

就地檢驗 (POCT)的全球市場:各產品 (血糖值計,血氣、電解質 (BGE) 分析設備,妊娠檢驗,傳染病檢查等)的未來展望

Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 409578
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
Back to Top
就地檢驗 (POCT)的全球市場:各產品 (血糖值計,血氣、電解質 (BGE) 分析設備,妊娠檢驗,傳染病檢查等)的未來展望 Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
出版日期: 2019年05月01日內容資訊: 英文 90 Pages
簡介

本報告提供全球就地檢驗 (POCT)的相關市場相關分析,照護現場診斷/檢驗概要,及市場整體及各產品、地區趨勢預測,主要的推動及阻礙市場要素,主要企業簡介、競爭策略,今後的技術開發、市場成長的方向性等的相關調查。

第1章 分析師的見解

第2章 分析方法

第3章 體外診斷市場概要

  • 簡介
  • 體外診斷是什麼?
  • 市場規模、成長率

第4章 照護現場診斷 (POCD):概要

第5章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會

第6章 就地檢驗 (POCT) 市場未來展望

第7章 POCT市場:各產品

  • 簡介
    • 血糖監測系統套件
    • 血氣、電解質分析設備
    • 妊娠、受精檢測套組
    • 傳染病檢查套件
    • 其他

第8章 POCT市場:各地區

  • 簡介
    • 北美
    • 歐洲
    • 亞太地區
    • 其他的國家 (RoW)

第9章 產業的趨勢、動靜

  • 攜帶式超音波設備,提供在現場的醫療
  • 微射流 (微小液體) 技術的POCT產業的滲透

第10章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.

As per RNCOS report "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022", the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.

Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.

The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.

The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

  • 3.1 Introduction
  • 3.2 What is In Vitro Diagnostics?
  • 3.3 Market Size and Growth

4. Point-of-Care Diagnostics: An Overview

5. Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
    • 5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
    • 5.1.3 Government Initiatives
    • 5.1.4 Technological Advancements
    • 5.1.5 Rising FDA Approvals
    • 5.1.6 Lack of Skilled Lab Personnel
    • 5.1.7 Rising Awareness about POCT
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Lack of Regulatory Standards
    • 5.2.3 Data Management & Connectivity
  • 5.3 Market Opportunities
    • 5.3.1 Physical Robotic Telepresence
    • 5.3.2 Smart Virtual Assistant in Association with Mobile Devices

6. Point-of-Care Testing Market Outlook 2022

7. Point-of-Care Testing Market, By Product

  • 7.1 Introduction
    • 7.1.1 Glucose Monitoring Kits
    • 7.1.2 Blood Gas and Electrolyte Analyzers
    • 7.1.3 Pregnancy & Fertility Testing Kits
    • 7.1.4 Cardiac Markers
    • 7.1.5 Infectious Diseases Testing Kits
    • 7.1.6 Drug-of-Abuse Testing Kits
    • 7.1.7 Others

8. Point-of-Care Testing Market, By Region

  • 8.1 Introduction
    • 8.1.1 North America
    • 8.1.2 Europe
    • 8.1.3 Asia Pacific
    • 8.1.4 Rest of the World

9. Industry Trends and Developments

  • 9.1 Portable Ultrasound Providing Care on Site
  • 9.2 Microfluidics Technology Crowding the POCT Industry

10. Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • 10.3 Siemens Healthineers
  • 10.4 Danaher Corporation
  • 10.5 Abbott Laboratories
  • 10.6 Johnson & Johnson
  • 10.7 OraSure Technologies, Inc.
  • 10.8 Thermo Fisher Scientific Inc.
  • 10.9 Medtronic plc

List of Figures

  • Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
  • Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
  • Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
  • Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
  • Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
  • Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
  • Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
  • Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
  • Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
  • Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
  • Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
  • Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2017
  • Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2017
  • Figure 10-3: Roche Diagnostics - Revenue by Segment (%), 2017
  • Figure 10-4: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 10-5: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 10-6: Abbott Laboratories - Revenue by Segment (%), 2017
  • Figure 10-7: Abbott Laboratories - Revenue by Geography (%), 2017
  • Figure 10-8: Johnson & Johnson - Revenue by Segment (%), 2017
  • Figure 10-9: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2017
  • Figure 10-10: Johnson & Johnson - Revenue by Geography (%), 2017
  • Figure 10-11: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2017
  • Figure 10-12: OraSure Technologies, Inc. - Revenue by Segment (%), 2017
  • Figure 10-13: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2017
  • Figure 10-14: OraSure Technologies, Inc. - Revenue by Geography (%), 2017
  • Figure 10-15: Thermo Fisher Scientific Inc. - Revenue by Segment (%), 2017
  • Figure 10-16: Thermo Fisher Scientific Inc. - Revenue by Geography (%), 2017
  • Figure 10-17: Medtronic plc - Revenue by Segment (%), 2017
  • Figure 10-18: Medtronic plc - Revenue by Geography (%), 2017

List of Tables:

  • Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
  • Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
  • Table 7-3: Home Pregnancy Test Kits
  • Table 10-1: Becton, Dickinson and Company - Net Sales (Million US$), 2015-2017
  • Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
  • Table 10-3: Roche Diagnostics - Net Sales (Million US$), 2015-2017
  • Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
  • Table 10-5: Siemens Healthineers - Net Sales (Million US$), 2015-2017
  • Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
  • Table 10-7: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
  • Table 10-9: Abbott Laboratories - Net Sales (Million US$), 2015-2017
  • Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
  • Table 10-11: Johnson & Johnson - Net Sales (Million US$), 2015-2017
  • Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
  • Table 10-13: OraSure Technologies, Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-15: Thermo Fisher Scientific Inc. - Net Sales (Million US$), 2015-2017
  • Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-17: Medtronic plc - Net Sales (Million US$), 2015-2017
  • Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
Back to Top